Virtual Surgical Planning in Mandibular Segmental Resection
Launched by UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY · Dec 7, 2023
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new way to plan surgeries for patients with certain benign tumors in the jawbone, specifically in the lower jaw (mandible). The goal is to see if using advanced technology, like 3D models and virtual planning, can lead to better surgical results compared to traditional methods. The researchers believe that this innovative approach could improve the accuracy of surgeries, enhance recovery, and ultimately provide a better quality of life for patients.
To be eligible for this trial, participants should be in good overall health and need surgery to remove a portion of their lower jaw. They must also be able to undergo anesthesia and agree to take part in the study. Those with certain conditions, such as infections in the jaw or a history of significant trauma in the area, will not be included. Participants can expect to be part of a study that compares two groups: one using the new virtual planning techniques and the other using standard surgical methods. If successful, this research could change how jaw surgeries are performed, making them safer and more effective for patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients indicated for mandibular segment resection and reconstruction plate placement.
- • Patients in overall good health suitable for undergoing anesthesia.
- • Patients who consent to the surgery and agree to participate in the study.
- Exclusion Criteria:
- • Patients indicated for temporomandibular joint dislocation due to invasive tumor.
- • Patients with infections in the mandible.
- • Patients with a history of trauma or surgery in the concave region of the mandible.
- • Patients with contraindications for surgery due to systemic diseases.
- • Patients without the conditions for postoperative follow-up and re-examination.
About University Of Medicine And Pharmacy At Ho Chi Minh City
The University of Medicine and Pharmacy at Ho Chi Minh City is a premier academic institution dedicated to advancing healthcare education and research in Vietnam. Renowned for its commitment to excellence in medical training, the university actively engages in innovative clinical trials aimed at improving patient outcomes and addressing pressing health challenges. By leveraging its extensive network of healthcare professionals and state-of-the-art facilities, the institution fosters collaboration between researchers, clinicians, and industry partners, ensuring the translation of scientific discoveries into effective medical practices. Through its rigorous ethical standards and dedication to patient safety, the university plays a vital role in enhancing the quality of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ho Chi Minh City, Ho Chi Minh, Vietnam
Patients applied
Trial Officials
Hung Tr Hoang, PhĐ
Principal Investigator
University of Medicine and Pharmacy at Ho Chi Minh City
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported